Literature DB >> 15448204

Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone.

Christine B Karim1, Tara L Kirby, Zhiwen Zhang, Yuri Nesmelov, David D Thomas.   

Abstract

We have used chemical synthesis and electron paramagnetic resonance to probe the structural dynamics of phospholamban (PLB) in lipid bilayers. Derivatives of monomeric PLB were synthesized, each of which contained a single spin-labeled 2,2,6,6,-Tetramethyl-piperidine-N-oxyl-4-amino-4-carboxylic acid amino acid, with the nitroxide-containing ring covalently and rigidly attached to the alpha-carbon, providing direct insight into the conformational dynamics of the peptide backbone. 2,2,6,6,-tetramethyl-piperidine-N-oxyl-4-amino-4-carboxylic acid was attached at positions 0, 11, and 24 in the cytoplasmic domain or at position 46 in the transmembrane domain. The electron paramagnetic resonance spectrum of the transmembrane domain site (position 46) indicates a single spectral component corresponding to strong immobilization of the probe, consistent with the presence of a stable and highly ordered transmembrane helix. In contrast, each of the three cytoplasmic domain probes has two clearly resolved spectral components (conformational states), one of which indicates nearly isotropic nanosecond dynamic disorder. For the probe at position 11, an N-terminal lipid anchor shifts the equilibrium toward the restricted component, whereas Mg(2+) shifts it in the opposite direction. Relaxation enhancement, due to Ni(2+) ions chelated to lipid head-groups, provides further information about the membrane topology of PLB, allowing us to confirm and refine a structural model based on previous NMR data. We conclude that the cytoplasmic domain of PLB is in a dynamic equilibrium between an ordered conformation, which is in direct contact with the membrane surface, and a dynamically disordered form, which is detached from the membrane and poised to interact with its regulatory target.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448204      PMCID: PMC521948          DOI: 10.1073/pnas.0402801101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Structural changes in the calcium pump accompanying the dissociation of calcium.

Authors:  Chikashi Toyoshima; Hiromi Nomura
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

2.  Solid-state NMR and rigid body molecular dynamics to determine domain orientations of monomeric phospholamban.

Authors:  Alessandro Mascioni; Christine Karim; Jamillah Zamoon; David D Thomas; Gianluigi Veglia
Journal:  J Am Chem Soc       Date:  2002-08-14       Impact factor: 15.419

Review 3.  A new spin on protein dynamics.

Authors:  Linda Columbus; Wayne L Hubbell
Journal:  Trends Biochem Sci       Date:  2002-06       Impact factor: 13.807

4.  Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure.

Authors:  K Haghighi; A G Schmidt; B D Hoit; A G Brittsan; A Yatani; J W Lester; J Zhai; Y Kimura; G W Dorn; D H MacLennan; E G Kranias
Journal:  J Biol Chem       Date:  2001-04-27       Impact factor: 5.157

5.  Identification of protein side chains near the membrane-aqueous interface: a site-directed spin labeling study of KcsA.

Authors:  Adrian Gross; Wayne L Hubbell
Journal:  Biochemistry       Date:  2002-01-29       Impact factor: 3.162

6.  Nitroxyl peptides as catalysts of enantioselective oxidations.

Authors:  Fernando Formaggio; Marcella Bonchio; Marco Crisma; Cristina Peggion; Stefano Mezzato; Alessandra Polese; Alessandra Barazza; Sabrina Antonello; Flavio Maran; Quirinus B Broxterman; Bernard Kaptein; Johan Kamphuis; Rosa Maria Vitale; Michele Saviano; Ettore Benedetti; Claudio Toniolo
Journal:  Chemistry       Date:  2002-01-04       Impact factor: 5.236

7.  Role of cysteine residues in structural stability and function of a transmembrane helix bundle.

Authors:  C B Karim; M G Paterlini; L G Reddy; G W Hunter; G Barany; D D Thomas
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

8.  Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase.

Authors:  C B Karim; C G Marquardt; J D Stamm; G Barany; D D Thomas
Journal:  Biochemistry       Date:  2000-09-05       Impact factor: 3.162

Review 9.  Phospholamban: a promising therapeutic target in heart failure?

Authors:  A G Schmidt; I Edes; E G Kranias
Journal:  Cardiovasc Drugs Ther       Date:  2001-09       Impact factor: 3.727

10.  Solid-phase synthesis of peptides containing the spin-labeled 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid (TOAC).

Authors:  L Martin; A Ivancich; C Vita; F Formaggio; C Toniolo
Journal:  J Pept Res       Date:  2001-11
View more
  58 in total

1.  (1)H/(15)N heteronuclear NMR spectroscopy shows four dynamic domains for phospholamban reconstituted in dodecylphosphocholine micelles.

Authors:  Emily E Metcalfe; Jamillah Zamoon; David D Thomas; Gianluigi Veglia
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

2.  Probing ground and excited states of phospholamban in model and native lipid membranes by magic angle spinning NMR spectroscopy.

Authors:  Martin Gustavsson; Nathaniel J Traaseth; Gianluigi Veglia
Journal:  Biochim Biophys Acta       Date:  2011-08-03

3.  The alpha-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation.

Authors:  M Germana Paterlini; David D Thomas
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

4.  Rotational dynamics of phospholamban determined by multifrequency electron paramagnetic resonance.

Authors:  Yuri E Nesmelov; Christine B Karim; Likai Song; Peter G Fajer; David D Thomas
Journal:  Biophys J       Date:  2007-06-15       Impact factor: 4.033

5.  Interactions between Ca2+-ATPase and the pentameric form of phospholamban in two-dimensional co-crystals.

Authors:  David L Stokes; Andrew J Pomfret; William J Rice; John Paul Glaves; Howard S Young
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

6.  Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells.

Authors:  Eileen M Kelly; Zhanjia Hou; Julie Bossuyt; Donald M Bers; Seth L Robia
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

7.  Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex.

Authors:  Zhanjia Hou; Eileen M Kelly; Seth L Robia
Journal:  J Biol Chem       Date:  2008-08-16       Impact factor: 5.157

8.  Time-resolved FRET reveals the structural mechanism of SERCA-PLB regulation.

Authors:  Xiaoqiong Dong; David D Thomas
Journal:  Biochem Biophys Res Commun       Date:  2014-05-09       Impact factor: 3.575

9.  Phospholamban and its phosphorylated form interact differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic study.

Authors:  Shadi Abu-Baker; Gary A Lorigan
Journal:  Biochemistry       Date:  2006-11-07       Impact factor: 3.162

10.  Mobility of TOAC spin-labelled peptides binding to the Src SH3 domain studied by paramagnetic NMR.

Authors:  Hanna E Lindfors; Peter E de Koning; Jan Wouter Drijfhout; Brigida Venezia; Marcellus Ubbink
Journal:  J Biomol NMR       Date:  2008-06-17       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.